Patents by Inventor Maarten JANMAAT

Maarten JANMAAT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AXL ANTIBODY-DRUG CONJUGATES FOR USE IN TREATING CANCER
    Publication number: 20220273809
    Abstract: The present invention relates to conjugates of antibodies and cytotoxic agents for use in treatment of cancer in combination with an inhibitor of PD-1 or PD-L1. The antibodies are directed against Axl.
    Type: Application
    Filed: July 17, 2020
    Publication date: September 1, 2022
    Inventors: Maarten JANMAAT, Nora PENCHEVA, Esther Cornelia Wilhelmina BREIJ, Julia BOSHUIZEN, Daniel Simon PEEPER, Ulf FORSSMANN, Tahamtan AHMADI, Patricia Garrido CASTRO
  • AXL-SPECIFIC ANTIBODIES FOR CANCER TREATMENT
    Publication number: 20210070869
    Abstract: The disclosure relates to anti-AXL antibodies, immunoconjugates, and compositions for treatment of cancer, which is resistant to or is predicted to be or become resistant to treatment with a programmed cell death-1/programmed cell death-1 ligand (PD-1/PD-L1) inhibitor.
    Type: Application
    Filed: April 10, 2019
    Publication date: March 11, 2021
    Inventors: Maarten JANMAAT, Esther BREIJ, Ulf FORSSMANN, Tahamtan AHMADI, Julia BOSHUIZEN, Daniel PEEPER, Nora PENCHEVA